Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Vaccinex Inc |
6/02 | 1,030 USD
-14,17% |
-14,17% |
Valbiotis SA |
6/02 | 1,094 EUR
-3,19% |
-3,19% |
|
Valneva SE |
6/02 | 4,028 EUR
-1,27% |
-1,27% |
|
Vanda Pharmaceuticals Inc |
6/02 | 7,570 USD
+4,70% |
+4,70% |
|
Varex Imaging Corp |
6/02 | 14,000 USD
+1,60% |
+1,60% |
|
Vaxart Inc |
6/02 | 0,600 USD
-7,39% |
-7,39% |
|
Vaxcyte Inc |
6/02 | 56,150 USD
+4,16% |
+4,16% |
Ventripoint Diagnostics Ltd |
6/02 | 0,125 CAD
+4,17% |
+4,17% |
Venture Life Group Plc |
6/02 | 69,500 GBX
+2,96% |
+2,96% |
|
Venus Concept Inc |
6/02 | 1,140 USD
-3,39% |
-3,39% |
|
Veracyte Inc |
6/02 | 36,190 USD
+3,82% |
+3,82% |
|
Verastem Inc |
6/02 | 6,670 USD
+6,21% |
+6,21% |
|
Vericel Corp |
6/02 | 36,190 USD
+2,29% |
+2,29% |
|
Verrica Pharmaceuticals Inc |
6/02 | 6,910 USD
+4,54% |
+4,54% |
|
Vertex Pharmaceuticals, Inc. |
6/02 | 477,920 USD
+4,17% |
+4,17% |
|
Veru Inc |
6/02 | 2,340 USD
+4,46% |
+4,46% |
|
Vetoquinol |
6/02 | 87,000 EUR
+1,64% |
+1,64% |
|
Viatris Inc |
6/02 | 14,580 USD
+1,67% |
+1,67% |
|
Viking Therapeutics Inc |
6/02 | 28,440 USD
+8,18% |
+8,18% |
|
Vir Biotechnology Inc |
6/02 | 7,190 USD
+3,90% |
+3,90% |
|
Virbac SA |
6/02 | 350,500 EUR
-0,71% |
-0,71% |
|
VistaGen Therapeutics Inc |
6/02 | 0,560 USD
+10,89% |
+10,89% |
Vita 34 AG |
6/02 | 5,300 EUR
0,00% |
0,00% |
|
Vivakor Inc |
6/02 | 0,009 USD
+17,11% |
+17,11% |
|
Viveve Medical Inc |
6/02 | 0,000 USD
+50,00% |
+50,00% |
Vivoryon Therapeutics |
6/02 | 1,428 EUR
-0,70% |
-0,70% |
|
VolitionRX Ltd |
6/02 | 0,246 USD
-0,40% |
-0,40% |
|
Voyager Therapeutics Inc |
6/02 | 3,680 USD
+3,95% |
+3,95% |
|
vTv Therapeutics Inc |
6/02 | 29,020 USD
-6,42% |
-6,42% |
|
VYNE Therapeutics Inc |
6/02 | 0,560 USD
+0,48% |
+0,48% |